Inventor
NAG BISHWAJIT
US40 patents
⚠️ This page may combine multiple inventors who share the name “NAG BISHWAJIT”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
CALYX THERAPEUTICS INC
10 patentsUS6624197B1Sep 23, 2003
Diphenylethylene compounds
CALYX THERAPEUTICS INC36 citations92
US6331633B1Dec 18, 2001
Heterocyclic analogs of diphenylethylene compounds
CALYX THERAPEUTICS INC35 citations92
US6245814B1Jun 12, 2001
Diphenylethylene compounds
CALYX THERAPEUTICS INC35 citations92
US6448450B1Sep 10, 2002
1-(3,5-dimethoxyphenyl)-2-(4-hydroxyphenyl)-ethylene for diabetes treatment
CALYX THERAPEUTICS INC23 citations86
US6194453B1Feb 27, 2001
Protein kinase inhibitor
CALYX THERAPEUTICS INC14 citations81
US6127338AOct 3, 2000
Orally active fraction of momordica charantia, active peptides thereof, and their use in the treatment of diabetes
CALYX THERAPEUTICS INC13 citations81
US6555702B2Apr 29, 2003
Protein kinase inhibitor
CALYX THERAPEUTICS INC11 citations72
US6525093B1Feb 25, 2003
Compounds to treat diabetes and associated conditions
CALYX THERAPEUTICS INC6 citations71
US6391854B1May 21, 2002
Orally active fraction of momordica charantia, active peptides thereof, and their use in the treatment of diabetes
CALYX THERAPEUTICS INC1 citations62
US6413504B1Jul 2, 2002
Alpha-arylated cinnamic esters and 1,4-bis(alpha-carboxyl-beta-styryl)benzene esters an UV-blocking agents
CALYX THERAPEUTICS INC2 citations60
ANERGEN INC
8 patentsUS5763585AJun 9, 1998
Method of making MHC-peptide complexes using metal chelate affinity chromatography
ANERGEN INC54 citations96
US5734023AMar 31, 1998
MHC class II β chain/peptide complexes useful in ameliorating deleterious immune responses
ANERGEN INC106 citations96
US5334391AAug 2, 1994
Intracellularly cleavable compounds
ANERGEN INC45 citations96
US5595881AJan 21, 1997
Method for the detection of antigen presenting cells
ANERGEN INC44 citations87
US6045796AApr 4, 2000
Vaccination with peptide of MHC class II molecules for treatment of autoimmune disease
ANERGEN INC17 citations83
US5169934ADec 8, 1992
Intracellularly cleavable compounds
ANERGEN INC20 citations82
US6007820ADec 28, 1999
Purification and characterization of MHC-peptide complexes useful in ameliorating autoimmunity
ANERGEN INC7 citations74
US5824315AOct 20, 1998
Binding affinity of antigenic peptides for MHC molecules
ANERGEN INC14 citations74
BEXEL PHARMACEUTICALS INC
7 patentsUS6794401B2Sep 21, 2004
Amino acid phenoxy ethers
BEXEL PHARMACEUTICALS INC19 citations91
US7087576B2Aug 8, 2006
Dipeptide phenyl ethers
BEXEL PHARMACEUTICALS INC12 citations82
US7521465B2Apr 21, 2009
Diphenyl ether derivatives
BEXEL PHARMACEUTICALS INC14 citations80
US7781464B2Aug 24, 2010
Heterocyclic diphenyl ethers
BEXEL PHARMACEUTICALS INC7 citations68
US7521466B2Apr 21, 2009
Dipeptide phenyl ethers
BEXEL PHARMACEUTICALS INC2 citations60
US7456292B2Nov 25, 2008
Hydroxamic acid-containing amino acid derivatives
BEXEL PHARMACEUTICALS INC4 citations57
US7399786B2Jul 15, 2008
Derivatives of amino acids for treatment of obesity and related disorders
BEXEL PHARMACEUTICALS INC5 citations55
THERACOS INC
6 patentsUS7105552B2Sep 12, 2006
Heterocyclic analogs of diphenylethylene compounds
THERACOS INC10 citations73
US6855732B2Feb 15, 2005
Compounds to treat diabetes and associated conditions
THERACOS INC6 citations71
US7202366B2Apr 10, 2007
Heterocyclic analogs of diphenylethylene compounds
THERACOS INC2 citations62
US6852695B2Feb 8, 2005
Orally active fraction of momordica charantia, active peptides thereof, and their use in the treatment of diabetes
THERACOS INC3 citations62
US7407978B2Aug 5, 2008
Heterocyclic analogs of diphenylethylene compounds
THERACOS INC1 citations48
US6723736B2Apr 20, 2004
Tricyclic compounds and uses thereof
THERACOS INC0 citations40
RENOVEL INNOVATIONS INC
6 patentsUS11807619B2Nov 7, 2023
Para acyl substituted diazacyclohexene derivatives
RENOVEL INNOVATIONS INC2 citations69
US11760743B2Sep 19, 2023
Acyloxy substituted phenyl dithiane derivatives
RENOVEL INNOVATIONS INC1 citations69
US12227487B1Feb 18, 2025
Acyloxy substituted phenyl dithiane derivatives
RENOVEL INNOVATIONS INC0 citations58
US12195418B2Jan 14, 2025
Halogenated benzylidene derivatives
RENOVEL INNOVATIONS INC0 citations58
US12195441B2Jan 14, 2025
Para acyl substituted diazacyclohexene derivatives
RENOVEL INNOVATIONS INC0 citations58
US11987551B2May 21, 2024
Styryl carboxylate derivatives
RENOVEL INNOVATIONS INC0 citations58